Results 281 to 290 of about 1,659,263 (293)

A Cost-Minimization Analysis Evaluating the Use of Liposomal Bupivacaine in Reconstructive Plastic Surgery Procedures

Plastic and Reconstructive Surgery, 2019
Background: Postsurgical pain management is critical to patient satisfaction and value. Several studies have evaluated liposomal bupivacaine in postoperative pain management protocols; however, its economic feasibility remains undefined.
A. Little, Kristin I. Brower, D. Keller, B. Ramshaw, J. Janis   +4 more
semanticscholar   +1 more source

Where Does Telemedicine Achieve a Cost Reduction Effect? Cost Minimization Analysis of Teleradiology Services in Japan

Telemedicine journal and e-health, 2019
Background: Telemedicine as a technology is expected to resolve issues such as doctor shortages and disparities in medical services. However, high costs of system installation and maintenance inhibit its widespread use.
Takumi Tanikawa, Reina Suzuki, Teppei Suzuki, Tomoki Ishikawa, Hiroko Yamashina, Shintaro Tsuji, K. Ogasawara   +6 more
semanticscholar   +1 more source

Cost‐minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulin

Journal of clinical apheresis, 2018
Therapeutic Plasma Exchange (TPE) and Intravenous Immunoglobulin both are first‐line treatments for Guillain Barre Syndrome; however, there is a significant difference in cost. We undertook this study to assess the cost minimization for treating Guillain
A. Maheshwari, Ratti Ram Sharma, S. Prinja, Rekha Hans, M. Modi, N. Sharma, N. Marwaha   +6 more
semanticscholar   +1 more source

Cost-minimization analysis of alemtuzumab compared to fingolimod and natalizumab for the treatment of active relapsing-remitting multiple sclerosis in the Netherlands

Journal of Medical Economics, 2018
Aim: In active relapsing remitting multiple sclerosis (RRMS) patients requiring second-line treatment, the Dutch National Health Care Institute (ZiN) has not stated a preference for either alemtuzumab, fingolimod, or natalizumab.
M. Piena, M. Heisen, L. W. Wormhoudt, J. V. Wingerden, S. Frequin, B. Uitdehaag   +5 more
semanticscholar   +1 more source

Cost-Minimization Analysis

Encyclopedia of Behavioral Medicine, 2020
A. Duenas
semanticscholar   +1 more source

What Are the Primary Cost Drivers of Anterior Cruciate Ligament Reconstruction in the United States? A Cost-Minimization Analysis of 14,713 Patients.

Arthroscopy: The Journal of Arthroscopy And Related, 2019
Steven L. Bokshan, Shayna R Mehta, S. DeFroda, B. Owens   +3 more
semanticscholar   +1 more source

The primary cost drivers of arthroscopic rotator cuff repair surgery: a cost-minimization analysis of 40,618 cases.

Journal of shoulder and elbow surgery, 2019
Lambert T. Li, Steven L. Bokshan, Lauren V. Ready, B. Owens   +3 more
semanticscholar   +1 more source

Cost minimization analysis for basic life support.

Resuscitation, 2019
Jordi Castillo, C. Gomar, E. Rodríguez, Marta Trapero, A. Gallart   +4 more
semanticscholar   +1 more source

Chapter 3: Cost-Minimization Analysis

A Practical Guide to Pharmacoeconomics, 2020

semanticscholar   +1 more source

Cost-minimization Analysis of the Management of Acute Achilles Tendon Rupture

Journal of the American Academy of Orthopaedic Surgeons, 2017
J. Truntzer, B. Triana, Alex H. S. Harris, Laurence C Baker, L. Chou, R. Kamal   +5 more
semanticscholar   +1 more source